Mohammad Ahsan Saad, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Photochemotherapy | 2 | 2022 | 823 | 1.030 |
Why?
|
| Phototherapy | 2 | 2023 | 368 | 0.790 |
Why?
|
| Coloring Agents | 1 | 2023 | 562 | 0.700 |
Why?
|
| Drug Carriers | 3 | 2017 | 706 | 0.610 |
Why?
|
| Nanoparticles | 5 | 2018 | 1959 | 0.530 |
Why?
|
| Immunoconjugates | 1 | 2023 | 954 | 0.520 |
Why?
|
| Photosensitizing Agents | 3 | 2023 | 623 | 0.460 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 1727 | 0.370 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 2895 | 0.330 |
Why?
|
| Gelatin | 2 | 2017 | 220 | 0.300 |
Why?
|
| Drug Delivery Systems | 3 | 2022 | 2226 | 0.290 |
Why?
|
| Lactoferrin | 1 | 2017 | 100 | 0.280 |
Why?
|
| Fluorescein | 1 | 2017 | 175 | 0.270 |
Why?
|
| Eye Infections, Fungal | 1 | 2017 | 100 | 0.270 |
Why?
|
| Solubility | 2 | 2023 | 1091 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 5368 | 0.230 |
Why?
|
| Keratitis | 1 | 2017 | 241 | 0.230 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 617 | 0.220 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 16981 | 0.210 |
Why?
|
| Neoplasms | 2 | 2022 | 22170 | 0.210 |
Why?
|
| Silicon | 1 | 2023 | 142 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2017 | 752 | 0.200 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 1027 | 0.180 |
Why?
|
| Nanomedicine | 1 | 2022 | 290 | 0.170 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 344 | 0.160 |
Why?
|
| Liposomes | 1 | 2022 | 784 | 0.160 |
Why?
|
| Oncolytic Virotherapy | 1 | 2023 | 516 | 0.150 |
Why?
|
| Immunotherapy | 2 | 2023 | 4652 | 0.140 |
Why?
|
| Water | 1 | 2023 | 1411 | 0.130 |
Why?
|
| Chitosan | 1 | 2017 | 131 | 0.130 |
Why?
|
| Molecular Imaging | 1 | 2023 | 815 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2023 | 3602 | 0.120 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2023 | 916 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 1903 | 0.120 |
Why?
|
| Drug Stability | 1 | 2015 | 291 | 0.120 |
Why?
|
| Meningioma | 1 | 2023 | 1218 | 0.120 |
Why?
|
| Sterilization | 1 | 2015 | 133 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2023 | 1248 | 0.120 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 306 | 0.110 |
Why?
|
| Drug Contamination | 1 | 2015 | 152 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 3877 | 0.100 |
Why?
|
| Particle Size | 2 | 2017 | 1648 | 0.100 |
Why?
|
| Glioma | 1 | 2017 | 3455 | 0.100 |
Why?
|
| Macrophages | 1 | 2017 | 5769 | 0.100 |
Why?
|
| Hydrogels | 1 | 2017 | 720 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1726 | 0.080 |
Why?
|
| Contrast Media | 1 | 2023 | 5311 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2023 | 3482 | 0.080 |
Why?
|
| Inflammation | 1 | 2017 | 10773 | 0.070 |
Why?
|
| Ketoconazole | 1 | 2017 | 97 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2017 | 1868 | 0.070 |
Why?
|
| Phase Transition | 1 | 2016 | 71 | 0.070 |
Why?
|
| Technology, Pharmaceutical | 1 | 2017 | 84 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 398 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2047 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 579 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2016 | 1229 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1848 | 0.050 |
Why?
|
| Protein Folding | 1 | 2016 | 870 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2496 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2017 | 18965 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1937 | 0.050 |
Why?
|
| Temperature | 1 | 2016 | 2226 | 0.040 |
Why?
|
| Cornea | 1 | 2017 | 1333 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 761504 | 0.040 |
Why?
|
| Antibodies | 1 | 2017 | 2418 | 0.040 |
Why?
|
| Animals | 5 | 2018 | 168459 | 0.030 |
Why?
|
| Drug Packaging | 1 | 2015 | 43 | 0.030 |
Why?
|
| Drug Storage | 1 | 2015 | 52 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2015 | 344 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 385 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2015 | 685 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 1541 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 23742 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 81525 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 2199 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3492 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64680 | 0.010 |
Why?
|